Yongbok Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Yongbok Kim has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Mark G. Trombetta
5 shared publicationsMoyed Miften
Department of Radiation Oncology; University of Colorado Denver; Aurora CO
4 shared publications- Mark Trombetta
Allegheny Health Network Cancer Institute, Professor of Radiation Oncology, Drexel University College of Medicine
3 shared publications David Parda
Allegheny General Hospital
2 shared publicationsDavid S. Parda
2 shared publicationsE Day Werts
2 shared publications
Latest Publications
- 1 September 2012
- Published by Elsevier in Brachytherapy
- Vol. 11 (5) , 380-386
Pacemaker/implantable cardioverter–defibrillator dose in balloon high-dose-rate brachytherapy for breast cancer treatment
- 1 September 2012
- Published by Elsevier in Brachytherapy
- Vol. 11 (5) , 380-386
Pacemaker/implantable cardioverter–defibrillator dose in balloon high-dose-rate brachytherapy for breast cancer treatment
- Open Access
- 1 February 2012
- Published by Sciedu Press in Journal of Solid Tumors
- Vol. 2 (1)
Mature follow-up of Low-dose rate interstitial brachytherapy following ipsilateral breast tumor recurrence in patients initially treated with breast conservation therapy
Objective: To evaluate our mature follow-up data in women who have developed IBTR following conservation surgeryand post-operative external radiotherapy retreated by lumpectomy followed by interstitial brachytherapy in lieu of salvagemastectomy.Methods: Between 1/1998 and 10/2006, twenty-two patients with TIS or T1 IBTR were offered interstitial low-dose ratebrachytherapy following tumor re-excision as an alternative to salvage mastectomy. All patients had failed lumpectomyfollowed by standard postoperative external beam radiotherapy (range 5000-6480cGy). The recurrent tumors were excisedwith final margins of resection free of residual disease. Tumor bed implantation was then carried out with an interstitialtechnique utilizing 192Iridium with the target volume consisting of the tumor bed plus a minimum 1.0 centimeter margin(minimum standard dose 4500cGy).Results: With a mean follow up of 67.5 months (range 17-115 months) Twenty-one of 22 patients maintained localcontrol at the time of last follow-up or at the time of their death. The single patient who developed a second localrecurrence was treated successfully with mastectomy. Three patients succumbed to systemic disease. Two patientsdeveloped localized skin breakdown. One patient developed a contralateral breast cancer. Long-term cosmetic results asdefined by the Harvard cosmesis scale and the Allegheny General modification were acceptable.Conclusions: These long-term data suggest that lumpectomy followed by brachytherapy is feasible and may be anacceptable alternative to salvage mastectomy in patients who locally fail conservation breast therapy. The upcomingRTOG retreatment trial (RTOG 1014) should help define the role of repeat conservation therapy in IBTR.
- 1 February 2012
- Published by Sciedu Press in Journal of Solid Tumors
- Vol. 2 (1)
Open AccessMature follow-up of Low-dose rate interstitial brachytherapy following ipsilateral breast tumor recurrence in patients initially treated with breast conservation therapy
Objective: To evaluate our mature follow-up data in women who have developed IBTR following conservation surgeryand post-operative external radiotherapy retreated by lumpectomy followed by interstitial brachytherapy in lieu of salvagemastectomy.Methods: Between 1/1998 and 10/2006, twenty-two patients with TIS or T1 IBTR were offered interstitial low-dose ratebrachytherapy following tumor re-excision as an alternative to salvage mastectomy. All patients had failed lumpectomyfollowed by standard postoperative external beam radiotherapy (range 5000-6480cGy). The recurrent tumors were excisedwith final margins of resection free of residual disease. Tumor bed implantation was then carried out with an interstitialtechnique utilizing 192Iridium with the target volume consisting of the tumor bed plus a minimum 1.0 centimeter margin(minimum standard dose 4500cGy).Results: With a mean follow up of 67.5 months (range 17-115 months) Twenty-one of 22 patients maintained localcontrol at the time of last follow-up or at the time of their death. The single patient who developed a second localrecurrence was treated successfully with mastectomy. Three patients succumbed to systemic disease. Two patientsdeveloped localized skin breakdown. One patient developed a contralateral breast cancer. Long-term cosmetic results asdefined by the Harvard cosmesis scale and the Allegheny General modification were acceptable.Conclusions: These long-term data suggest that lumpectomy followed by brachytherapy is feasible and may be anacceptable alternative to salvage mastectomy in patients who locally fail conservation breast therapy. The upcomingRTOG retreatment trial (RTOG 1014) should help define the role of repeat conservation therapy in IBTR.
- 22 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 2053-2057
Objective method to report planner‐independent skin/rib maximal dose in balloon‐based high dose rate (HDR) brachytherapy for breast cancer
An objective method was proposed and compared with a manual selection method to determine planner-independent skin and rib maximal dose in balloon-based high dose rate (HDR) brachytherapy planning. The maximal dose to skin and rib was objectively extracted from a dose volume histogram (DVH) of skin and rib volumes. A virtual skin volume was produced by expanding the skin surface in three dimensions (3D) external to the breast with a certain thickness in the planning computed tomography (CT) images. Therefore, the maximal dose to this volume occurs on the skin surface the same with a conventional manual selection method. The rib was also delineated in the planning CT images and its maximal dose was extracted from its DVH. The absolute (Abdiff = [D(max) Man - D (max)DVH]) and relative (Rediff[%] = 100 x ([D(max)Man-D(max)DVH])/D(max)DVH) maximal skin and rib dose differences between the manual selection method (D(max)Man) and the objective method (D(max)DVH) were measured for 50 balloon-based HDR (25 MammoSite and 25 Contura) patients. The average +/- standard deviation of maximal dose difference was 1.67% +/- 1.69% of the prescribed dose (PD). No statistical difference was observed between MammoSite and Contura patients for both Abdiff and Rediff[%] values. However, a statistically significant difference (p value < 0.0001) was observed in maximal rib dose difference compared with maximal skin dose difference for both Abdiff (2.30% +/- 1.71% vs 1.05% +/- 1.43%) and Rediff[%] (2.32% +/- 1.79% vs 1.21% +/- 1.41%). In general, rib has a more irregular contour and it is more proximally located to the balloon for 50 HDR patients. Due to the inverse square law factor, more dose difference was observed in higher dose range (D(max) > 90%) compared with lower dose range (D(max) < 90%): 2.16% +/- 1.93% vs 1.19% +/- 1.25% with p value of 0.0049. However, the Rediff[%] analysis eliminated the inverse square factor and there was no statistically significant difference (p value = 0.8931) between high and low dose ranges. The objective method using volumetric information of skin and rib can determine the planner-independent maximal dose compared with the manual selection method. However, the difference was < 2% of PD, on average, if appropriate attention is paid to selecting a manual dose point in 3D planning CT images.
- 22 March 2011
- Published by Wiley in Medical Physics
- Vol. 38 (4) , 2053-2057
Objective method to report planner‐independent skin/rib maximal dose in balloon‐based high dose rate (HDR) brachytherapy for breast cancer
An objective method was proposed and compared with a manual selection method to determine planner-independent skin and rib maximal dose in balloon-based high dose rate (HDR) brachytherapy planning. The maximal dose to skin and rib was objectively extracted from a dose volume histogram (DVH) of skin and rib volumes. A virtual skin volume was produced by expanding the skin surface in three dimensions (3D) external to the breast with a certain thickness in the planning computed tomography (CT) images. Therefore, the maximal dose to this volume occurs on the skin surface the same with a conventional manual selection method. The rib was also delineated in the planning CT images and its maximal dose was extracted from its DVH. The absolute (Abdiff = [D(max) Man - D (max)DVH]) and relative (Rediff[%] = 100 x ([D(max)Man-D(max)DVH])/D(max)DVH) maximal skin and rib dose differences between the manual selection method (D(max)Man) and the objective method (D(max)DVH) were measured for 50 balloon-based HDR (25 MammoSite and 25 Contura) patients. The average +/- standard deviation of maximal dose difference was 1.67% +/- 1.69% of the prescribed dose (PD). No statistical difference was observed between MammoSite and Contura patients for both Abdiff and Rediff[%] values. However, a statistically significant difference (p value < 0.0001) was observed in maximal rib dose difference compared with maximal skin dose difference for both Abdiff (2.30% +/- 1.71% vs 1.05% +/- 1.43%) and Rediff[%] (2.32% +/- 1.79% vs 1.21% +/- 1.41%). In general, rib has a more irregular contour and it is more proximally located to the balloon for 50 HDR patients. Due to the inverse square law factor, more dose difference was observed in higher dose range (D(max) > 90%) compared with lower dose range (D(max) < 90%): 2.16% +/- 1.93% vs 1.19% +/- 1.25% with p value of 0.0049. However, the Rediff[%] analysis eliminated the inverse square factor and there was no statistically significant difference (p value = 0.8931) between high and low dose ranges. The objective method using volumetric information of skin and rib can determine the planner-independent maximal dose compared with the manual selection method. However, the difference was < 2% of PD, on average, if appropriate attention is paid to selecting a manual dose point in 3D planning CT images.
- Open Access
- 10 June 2010
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 11 (3) , 124-134
Evaluation of the interfractional biological effective dose (BED) variation in MammoSite high dose rate brachytherapy
- 10 June 2010
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 11 (3) , 124-134
Open AccessEvaluation of the interfractional biological effective dose (BED) variation in MammoSite high dose rate brachytherapy
- Open Access
- 28 May 2010
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 11 (3) , 54-63
Comparison of single and multiple dwell position methods in MammoSite high dose rate (HDR) brachytherapy planning
The purpose of this study is to dosimetrically compare two plans generated using single dwell position method (SDPM) and multiple dwell position methods (MDPM) in MammoSite high dose rate (HDR) brachytherapy planning for 19 breast cancer patients. In computed tomography (CT) image‐based HDR planning, a surface optimization technique was used in both methods. Following dosimetric parameters were compared for fraction 1 plans: %PTV_EVAL (planning target volume for plan evaluation) coverage, dose homogeneity index (DHI), dose conformal index (COIN), maximum dose to skin and ipsilateral lung, and breast tissue volume receiving 150% (V150[cc]) and 200% (V200[cc]) of the prescribed dose. In addition, a plan was retrospectively generated for each fraction 2–10 to simulate the clinical situation where the fraction 1 plan was used for fractions 2–10 without modification. In order to create nine derived plans for each method and for each of the 19 patients, the catheter location and contours of target and critical structures were defined on the CT images acquired prior to each fraction 2–10, while using the same dwell‐time distribution as used for fraction 1 (original plan). Interfraction dose variations were evaluated for 19 patients by comparing the derived nine plans (each for fractions 2–10) with the original plan (fraction 1) using the same dosimetric parameters used for fraction 1 plan comparison. For the fraction 1 plan comparison, the MDPM resulted in slightly increased %PTV_EVAL coverage, COIN, V150[cc] and V200[cc] values by an average of 1.2%, 0.025, 0.5 cc and 0.7 cc, respectively, while slightly decreased DHI, maximum skin and ipsilateral lung dose by an average of 0.003, 3.2 cGy and 5.8 cGy, respectively. For the interfraction dose variation comparison, the SDPM resulted in slightly smaller variations in %PTV_EVAL coverage, DHI, maximum skin dose and V150[cc] values by an average of 0.4%, 0.0005, 0.5 cGy and 0.2 cc, respectively, while slightly higher average variations in COIN, maximum ipsilateral lung dose and V200[cc] values by 0.0028, 0.2 cGy and 0.2 cc, respectively. All differences were too small to be clinically significant. Compared to the MDPM, the SDPM combined with a surface optimization technique can generate a clinically comparable fraction 1 treatment plan with a similar interfraction dose variation if a single source is carefully positioned at the center of the balloon catheter.PACS number: 87.53.Jw
- 28 May 2010
- Published by Wiley in Journal of Applied Clinical Medical Physics
- Vol. 11 (3) , 54-63
Open AccessComparison of single and multiple dwell position methods in MammoSite high dose rate (HDR) brachytherapy planning
The purpose of this study is to dosimetrically compare two plans generated using single dwell position method (SDPM) and multiple dwell position methods (MDPM) in MammoSite high dose rate (HDR) brachytherapy planning for 19 breast cancer patients. In computed tomography (CT) image‐based HDR planning, a surface optimization technique was used in both methods. Following dosimetric parameters were compared for fraction 1 plans: %PTV_EVAL (planning target volume for plan evaluation) coverage, dose homogeneity index (DHI), dose conformal index (COIN), maximum dose to skin and ipsilateral lung, and breast tissue volume receiving 150% (V150[cc]) and 200% (V200[cc]) of the prescribed dose. In addition, a plan was retrospectively generated for each fraction 2–10 to simulate the clinical situation where the fraction 1 plan was used for fractions 2–10 without modification. In order to create nine derived plans for each method and for each of the 19 patients, the catheter location and contours of target and critical structures were defined on the CT images acquired prior to each fraction 2–10, while using the same dwell‐time distribution as used for fraction 1 (original plan). Interfraction dose variations were evaluated for 19 patients by comparing the derived nine plans (each for fractions 2–10) with the original plan (fraction 1) using the same dosimetric parameters used for fraction 1 plan comparison. For the fraction 1 plan comparison, the MDPM resulted in slightly increased %PTV_EVAL coverage, COIN, V150[cc] and V200[cc] values by an average of 1.2%, 0.025, 0.5 cc and 0.7 cc, respectively, while slightly decreased DHI, maximum skin and ipsilateral lung dose by an average of 0.003, 3.2 cGy and 5.8 cGy, respectively. For the interfraction dose variation comparison, the SDPM resulted in slightly smaller variations in %PTV_EVAL coverage, DHI, maximum skin dose and V150[cc] values by an average of 0.4%, 0.0005, 0.5 cGy and 0.2 cc, respectively, while slightly higher average variations in COIN, maximum ipsilateral lung dose and V200[cc] values by 0.0028, 0.2 cGy and 0.2 cc, respectively. All differences were too small to be clinically significant. Compared to the MDPM, the SDPM combined with a surface optimization technique can generate a clinically comparable fraction 1 treatment plan with a similar interfraction dose variation if a single source is carefully positioned at the center of the balloon catheter.PACS number: 87.53.Jw
- 1 October 2009
- Vol. 23 (11) , 954-6
The allegheny general modification of the Harvard Breast Cosmesis Scale for the retreated breast.
The use of brachytherapy--and to a lesser extent, external-beam radiotherapy--in the management of locally recurrent breast cancer following ipsilateral breast tumor recurrence (IBTR) followed by repeat breast-conservation surgery and irradiation is currently an area of intense study. The current cosmetic scoring system is inadequate to score the outcome resulting from retreatment because it does not account for the cosmetic effect of the initial treatment. We propose a modification of the scale for patients who undergo retreatment--the Allegheny General Modification of the Harvard/NSABP/RTOG scoring scale.
- 1 October 2009
- Vol. 23 (11) , 954-6
The allegheny general modification of the Harvard Breast Cosmesis Scale for the retreated breast.
The use of brachytherapy--and to a lesser extent, external-beam radiotherapy--in the management of locally recurrent breast cancer following ipsilateral breast tumor recurrence (IBTR) followed by repeat breast-conservation surgery and irradiation is currently an area of intense study. The current cosmetic scoring system is inadequate to score the outcome resulting from retreatment because it does not account for the cosmetic effect of the initial treatment. We propose a modification of the scale for patients who undergo retreatment--the Allegheny General Modification of the Harvard/NSABP/RTOG scoring scale.
- 14 November 2007
- Published by Wiley in Medical Physics
- Vol. 34 (12) , 4640-4648
Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer
A dosimetric comparison was performed on external‐beam three‐dimensional conformal partial breast irradiation (PBI) and whole breast irradiation (WBI) plans for patients enrolled in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B‐39/Radiation Therapy Oncology Group (RTOG) 0413 protocol at our institution. Twenty‐four consecutive patients were treated with either PBI (12 patients) or WBI (12 patients). In the PBI arm, the lumpectomy cavity was treated to a total dose of 38.5 Gy at 3.85 Gy per fraction twice daily using a four‐field noncoplanar beam setup. A minimum 6 h interval was required between fractions. In the WBI arm, the whole breast including the entirety of the lumpectomy cavity was treated to a total dose of 50.4 Gy at 1.8 Gy per fraction daily using opposed tangential beams. The lumpectomy cavity volume, planning target volume for evaluation (PTV_EVAL), and critical structure volumes were contoured for both the PBI and WBI patients. Dosimetric parameters, dose volume histograms (DVHs), and generalized equivalent uniform dose (gEUD) for target and critical structures were compared. Dosimetric results show the PBI plans, compared to the WBI plans, have smaller hot spots in the PTV_EVAL (maximum dose: versus ) and reduced dose to the ipsilateral breast (: versus and : versus ), contralateral breast (: versus ), ipsilateral lung (: versus ), and thyroid (maximum dose: versus ) with values . However, similar dose coverage of the PTV_EVAL ( for PBI and for WBI, on average) was observed and the dose difference for other critical structures was clinically insignificant in both arms. The gEUD data analysis showed the reduction of dose to the ipsilateral breast and lung, contralateral breast and thyroid. In addition, preliminary dermatologic adverse event assessment data suggested reduced skin toxicity for patients treated with the PBI technique.
- 14 November 2007
- Published by Wiley in Medical Physics
- Vol. 34 (12) , 4640-4648
Dosimetric comparison of partial and whole breast external beam irradiation in the treatment of early stage breast cancer
A dosimetric comparison was performed on external‐beam three‐dimensional conformal partial breast irradiation (PBI) and whole breast irradiation (WBI) plans for patients enrolled in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B‐39/Radiation Therapy Oncology Group (RTOG) 0413 protocol at our institution. Twenty‐four consecutive patients were treated with either PBI (12 patients) or WBI (12 patients). In the PBI arm, the lumpectomy cavity was treated to a total dose of 38.5 Gy at 3.85 Gy per fraction twice daily using a four‐field noncoplanar beam setup. A minimum 6 h interval was required between fractions. In the WBI arm, the whole breast including the entirety of the lumpectomy cavity was treated to a total dose of 50.4 Gy at 1.8 Gy per fraction daily using opposed tangential beams. The lumpectomy cavity volume, planning target volume for evaluation (PTV_EVAL), and critical structure volumes were contoured for both the PBI and WBI patients. Dosimetric parameters, dose volume histograms (DVHs), and generalized equivalent uniform dose (gEUD) for target and critical structures were compared. Dosimetric results show the PBI plans, compared to the WBI plans, have smaller hot spots in the PTV_EVAL (maximum dose: versus ) and reduced dose to the ipsilateral breast (: versus and : versus ), contralateral breast (: versus ), ipsilateral lung (: versus ), and thyroid (maximum dose: versus ) with values . However, similar dose coverage of the PTV_EVAL ( for PBI and for WBI, on average) was observed and the dose difference for other critical structures was clinically insignificant in both arms. The gEUD data analysis showed the reduction of dose to the ipsilateral breast and lung, contralateral breast and thyroid. In addition, preliminary dermatologic adverse event assessment data suggested reduced skin toxicity for patients treated with the PBI technique.